학술논문

Potential Predictive Markers in Protocol Biopsies for Premature Renal Graft Loss.
Document Type
Article
Source
Kidney & Blood Pressure Research. 2010, Vol. 33 Issue 1, p7-14. 8p. 4 Charts, 2 Graphs.
Subject
*BIOPSY
*HOMOGRAFTS
*KIDNEYS
*MESSENGER RNA
*POLYMERASE chain reaction
*CYTOKINES
*CHEMOKINES
Language
ISSN
1420-4096
Abstract
Background/Aims: Protocol biopsies offer new possibilities to predict kidney allograft outcome. The aim of this study was to find clinical, laboratory, morphological and molecular predictors of short-term renal graft survival. Methods: Three-month protocol kidney graft biopsy was carried out on 257 patients. The real-time RT-PCR was used to identify intragraft mRNA expression of several cytokines and chemokines and predictive statistics was performed to find markers connected with the risk of premature graft failure. Results: Compared to patients with normal morphology at 3 months, patients with subclinical rejection including borderline changes had experienced more frequent (p < 0.001) acute rejections before 3-month biopsy, serum creatinine ≥170 μmol/l (p < 0.01), and higher intrarenal expression of RANTES, IP-10 (p < 0.001), C3, CD3, IgJ (p < 0.01) and CD20 (p < 0.05). There was a significant correlation between subclinical rejection and the occurrence of late acute rejection and graft failure at the first year after transplantation. Moreover, higher RANTES and IP-10 expressions in subclinical rejection predicted graft loss at one year after transplantation in the univariate analysis. Conclusions: Patients with subclinical rejection including borderline changes in 3-month biopsy and particularly those with higher intrarenal expression of RANTES and IP-10 mRNA were found to be at risk for premature kidney graft loss. Copyright © 2010 S. Karger AG, Basel [ABSTRACT FROM AUTHOR]